Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

PIALOUX

Showing results (421-430 of 578) with videos related to

Pageof 58
Sort By:
Clinical and Vaccine Immunology : CVI|January 11, 2008
Immunological responses and long-term treatment interruption after human immunodeficiency virus type 1 (HIV-1) lipopeptide immunization of HIV-1-infected patients: the LIPTHERA studyGilles Pialoux, Romina P Quercia, Hanne Gahery, et al.
BMJ Open|April 8, 2022
Effect of acute aerobic exercise before immunotherapy and chemotherapy infusion in patients with metastatic non-small-cell lung cancer: protocol for the ERICA feasibility trialManon Gouez, Olivia Pérol, Maurice Pérol, et al.
Gut|October 18, 2000
Safety and efficacy of interferon-ribavirin combination therapy in HCV-HIV coinfected subjects: an early reportH Zylberberg, Y Benhamou, J L Lagneaux, et al.
European Journal of Applied Physiology|June 21, 2006
Living high-training low: effect on erythropoiesis and maximal aerobic performance in elite Nordic skiersPaul Robach, Laurent Schmitt, Julien V Brugniaux, et al.
Clinical Journal of the American Society of Nephrology : CJASN|February 23, 2013
Tubulointerstitial nephropathies in HIV-infected patients over the past 15 years: a clinico-pathological studyMohamad Zaidan, François-Xavier Lescure, Isabelle Brochériou, et al.
Human Pathology|January 9, 2018
Decreased expression of megalin and cubilin and altered mitochondrial activity in tenofovir nephrotoxicityAlexandre Cez, Isabelle Brocheriou, François-Xavier Lescure, et al.
Open Forum Infectious Diseases|April 2, 2021
Inflammatory Markers During Early Treatment of Seroconverters in a Randomized Placebo-Controlled Trial of PrEP (ANRS-IPERGAY)Sylvain Chawki, Isabelle Charreau, Audrey Gabassi, et al.
HIV Medicine|August 9, 2022
Missed opportunities for HIV pre-exposure prophylaxis among people with recent HIV infection: The French ANRS 95041 OMaPrEP studyCaroline Lions, Helene Laroche, Marion Mora, et al.
AIDS (London, England)|June 12, 2010
Factors predictive of virological failure on atazanavir in 310 HIV-infected patientsFrançois-Xavier Lescure, Jean-Marie Poirier, Jean-Luc Meynard, et al.
AIDS Research and Human Retroviruses|August 24, 2004
Use of well-defined HIV-derived epitopes to evaluate CD4(+) and CD8(+) T cell responses in patients with chronic HIV-1 infection treated with HAARTNathalie Daniel, Bénédicte Charmeteau, Sophie Grabar, et al.
Pageof 58

Showing results (421-430 of 578) with videos related to

Sort By:
Pageof 58
Clinical and Vaccine Immunology : CVI|January 11, 2008
Immunological responses and long-term treatment interruption after human immunodeficiency virus type 1 (HIV-1) lipopeptide immunization of HIV-1-infected patients: the LIPTHERA studyGilles Pialoux, Romina P Quercia, Hanne Gahery, et al.
BMJ Open|April 8, 2022
Effect of acute aerobic exercise before immunotherapy and chemotherapy infusion in patients with metastatic non-small-cell lung cancer: protocol for the ERICA feasibility trialManon Gouez, Olivia Pérol, Maurice Pérol, et al.
Gut|October 18, 2000
Safety and efficacy of interferon-ribavirin combination therapy in HCV-HIV coinfected subjects: an early reportH Zylberberg, Y Benhamou, J L Lagneaux, et al.
European Journal of Applied Physiology|June 21, 2006
Living high-training low: effect on erythropoiesis and maximal aerobic performance in elite Nordic skiersPaul Robach, Laurent Schmitt, Julien V Brugniaux, et al.
Clinical Journal of the American Society of Nephrology : CJASN|February 23, 2013
Tubulointerstitial nephropathies in HIV-infected patients over the past 15 years: a clinico-pathological studyMohamad Zaidan, François-Xavier Lescure, Isabelle Brochériou, et al.
Human Pathology|January 9, 2018
Decreased expression of megalin and cubilin and altered mitochondrial activity in tenofovir nephrotoxicityAlexandre Cez, Isabelle Brocheriou, François-Xavier Lescure, et al.
Open Forum Infectious Diseases|April 2, 2021
Inflammatory Markers During Early Treatment of Seroconverters in a Randomized Placebo-Controlled Trial of PrEP (ANRS-IPERGAY)Sylvain Chawki, Isabelle Charreau, Audrey Gabassi, et al.
HIV Medicine|August 9, 2022
Missed opportunities for HIV pre-exposure prophylaxis among people with recent HIV infection: The French ANRS 95041 OMaPrEP studyCaroline Lions, Helene Laroche, Marion Mora, et al.
AIDS (London, England)|June 12, 2010
Factors predictive of virological failure on atazanavir in 310 HIV-infected patientsFrançois-Xavier Lescure, Jean-Marie Poirier, Jean-Luc Meynard, et al.
AIDS Research and Human Retroviruses|August 24, 2004
Use of well-defined HIV-derived epitopes to evaluate CD4(+) and CD8(+) T cell responses in patients with chronic HIV-1 infection treated with HAARTNathalie Daniel, Bénédicte Charmeteau, Sophie Grabar, et al.
Pageof 58